World-First Trial Seeks to Assess Driving Skills of Medicinal Cannabis Users

Victoria is taking a bold leap with a world-first medicinal cannabis driving trial, putting users to the test to see if they can safely navigate the road under the influence of THC, the psychoactive ingredient in cannabis. Medicinal cannabis products typically contain varying concentrations of delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD). There is currently limited evidence about the impact of prescribed THC-containing medicinal cannabis on real-world driver performance. Funded by a $4.9 million state grant and led by Swinburne University, the trial will closely examine whether medicinal cannabis patients pose a risk behind the wheel—or if the stigma of impaired driving may be overstated....